4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cadrenal Therapeutics, Inc. (CVKD) operates in the Biotechnology industry and is headquartered in Ponte Vedra, United States with about 5 employees. Its market capitalization is roughly $7 million. In the fiscal year ended 2025-12-31, CVKD reported $0M in revenue and ($13M) in net income.
Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | $0M | $0M | $0M |
| Operating Income (EBIT) | ($14M) | ($11M) | ($8M) |
| Net Income | ($13M) | ($11M) | ($8M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($3M) | ($3M) | ($4M) | ($4M) | — |
| Net Income | ($2M) | ($3M) | ($3M) | ($4M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $4M | $10M | $8M | $1M |
| Total Liabilities | $2M | $3M | $1M | $6M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CVKD viewer.
About TickerBase · Data methodology & sources